Finanzwire Finanzwire
Basculer en Français
10336 Companies
214540 Keywords
144364 Articles
113636 Press releases
Headlines Articles Press releases EspeRare Foundation Remove
  1. Home
  2. Companies
  3. EspeRare Foundation
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 01/13/2026 at 15:20, 3 months 19 days ago

    N-Lorem and EspeRare Collaborate to Enhance Access to ASO Therapies in Europe

    EspeRare N-Lorem ASO Therapies Rare Genetic Diseases European Collaboration
  • PRESS RELEASE

    published on 01/13/2026 at 15:15, 3 months 19 days ago

    n-Lorem and EspeRare announce European collaboration to expand access to individualized ASO Therapies for Rare Genetic Diseases

    n-Lorem and EspeRare collaborate to expand access to individualized ASO Therapies for Rare Genetic Diseases in Europe, focusing on Switzerland and EU, to develop regulatory and clinical pathways
    EspeRare N-Lorem ASO Therapies Rare Genetic Diseases European Collaboration
    Logo of EspeRare Foundation
  • BRIEF

    published on 12/03/2025 at 18:45, 4 months 29 days ago

    EspeRare Secures Gates Foundation Grant for Preeclampsia Therapy

    Therapy Development Maternal Health Gates Foundation Preeclampsia EspeRare
  • PRESS RELEASE

    published on 12/03/2025 at 18:40, 4 months 29 days ago

    EspeRare receives a grant from the Gates Foundation to advance a novel therapy for preeclampsia

    EspeRare receives a grant from the Gates Foundation to advance a novel therapy for preeclampsia. The grant supports their mission to bring life-changing therapies to under-resourced settings worldwide
    Grant Gates Foundation Preeclampsia EspeRare Therapy
    Logo of EspeRare Foundation
Accesswire
  • Published on 05/01/2026 at 22:30, 20 minutes ago

    Nextech3D.ai Appoints New Independent Auditor

  • Published on 05/01/2026 at 22:30, 20 minutes ago

    Integrated Rewards Achieves SOC 2 Compliance to Support Enterprise-Scale Growth Across Canada's Card-Linked Rewards Network as EQ Closes Convertible Debt Financing

  • Published on 05/01/2026 at 22:30, 20 minutes ago

    Apex Critical Metals Announces Extension of Marketing Agreement with Rumble Strip Media Inc.

  • Published on 05/01/2026 at 18:00, 4 hours 50 minutes ago

    Star Copper to Present at the Emerging Growth Conference on May 7, 2026

  • Published on 05/01/2026 at 15:35, 7 hours 15 minutes ago

    LNG Energy Group Announces Partial Revocation of Cease Trade Order and Proposed Private Placement

View all ACCESSWIRE
EQS Group
  • Published on 05/01/2026 at 19:23, 3 hours 27 minutes ago

    Fuller, Smith & Turner PLC: Transaction in own shares

  • Published on 05/01/2026 at 18:40, 4 hours 10 minutes ago

    Holding(s) in Company

  • Published on 05/01/2026 at 17:47, 5 hours 3 minutes ago

    Key Figures 30.04.2026

  • Published on 05/01/2026 at 17:45, 5 hours 5 minutes ago

    Burkhalter Group acquires Progressio Holding GmbH and anplaq ag, Tamins (GR)

  • Published on 05/01/2026 at 17:21, 5 hours 29 minutes ago

    Fuller, Smith & Turner PLC: Total Voting Rights and Treasury Shares

View all EQS
Les Echos
  • Published on 04/30/2026 at 20:00, 1 day 2 hours ago

    AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue

  • Published on 04/30/2026 at 19:16, 1 day 3 hours ago

    AXA announces the results of its Shareholders' Meeting

  • Published on 04/30/2026 at 19:00, 1 day 3 hours ago

    Capital increase through exercise of subscription rights

  • Published on 04/30/2026 at 18:10, 1 day 4 hours ago

    Minutes of the Combined General Meeting held on April 30, 2026

  • Published on 04/30/2026 at 18:00, 1 day 4 hours ago

    TF1 Q1 2026 results - Press release

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy